Cite
MLA Citation
J.G. Berdeja et al.. “Clinical remissions and limited toxicity in a first-in-human multicenter study of bb2121, a novel anti-BCMA CAR T cell therapy for relapsed/refractory multiple myeloma.” European journal of cancer, vol. 69, n.d., pp. S5–. http://access.bl.uk/ark:/81055/vdc_100039473315.0x000040